Abstract
The effects of pre-treatment with ENA-713, an acetylcholinesterase (AChE) inhibitor, on changes in pre- and postsynaptic cholinergic indices in gerbil brain following transient ischemia were studied at 4 and 14 days after recirculation. In the ischemic group, hippocampal acetylcholine (ACh) level was significantly reduced (to 23% of sham-operated controls) at 4 days post-ischemia, but this reduction was completely prevented by ENA-713 treatment. Choline acetyltransferase (ChAT) and cholinesterase (ChE) activities were not significantly changed at 4 and 14 days post-ischemia. Although the maximum number (Bmax) of muscarinic ACh receptor (mACh-R) binding in the hippocampus was decreased (to 44%) without any change in affinity at 14 days post-ischemia, this decrease was also inhibited by ENA-713 treatment. In addition, histological experiment indicated that ENA-713 inhibited ischemia-induced pyramidal cell loss in the hippocampal CA1 regions. Thus, these findings suggest that ENA-713 has protective, neurotrophic and therapeutic effects on cerebrovascular type dementia due to cerebral ischemia.
Similar content being viewed by others
References
Whitehouse, P. J. 1987. Neurotransmitter receptor alterations in Alzheimer disease: A review. Alzheimer disease and associated disorders 1:9–18.
Thal, L. J., Masur, D. M., Fuld, P. A., Sharpless, N. S., and Davies, P. 1983. Memory improvement with oral physostigmine and lecithin in Alzheimer's disease. Biological Aspects of Alzheimer's Disease. Banbury Rep 15:461–469.
Bartus, R. T., Dean, R. L., Beer, B., and Lippa, A. S. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417.
Davis, K. L., and Mohs, R. C. 1982. Enhancement of memory processes in Alzheimer type with multiple dose intravenous physostigmine. Am. J. Psychiat. 139:1421–1424.
Traft, W. C., Clifton, G. L., Blair, R. E., and Edlorenzo, R. J. 1989. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res. 483:143–148.
Nilson, B., and Ponten, U. 1977. Experimental head injury in the rat. Part 2: regional brain energy metabolism in concussive trauma. J. Neurosurg. 47:252–261.
Bes, A., Jauzac, P., Guell, A., Broak, L., and Gerand, G. 1978. Hemodynamic and metabolic factors in human cerebral ischemia. Eur. Neurol. suppl. 1, 17:17–26.
Asplund, K., Hagg, E., Helmers, C., Lithner, F., Strand, T., and Wester, P. O. 1980. The natural history of stroke in diabetic patients. Acta Med. Scand. 207:417–424.
Pulsinelli, W. A., Levy, D. E., Sigsbee, B., Scherer, P., and Plum, F. 1983. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am. J. Med. 74:540–544.
Francis, A., and Pulsinelli, W. 1982. The response of GABAergic and cholinergic neurons to transient cerebral ischemia. Brain Res. 243:271–278.
Kirino, T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:57–69.
Pulsinelli, W. A., Brierley, J. B., and Plum, F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:491–498.
Haba, K., Ogawa, N., Mizukawa, K., and Mori, A. 1991. Time course of changes in lipid peroxidation, pre- and postsynaptic cholinergic indices, NMDA receptor binding and neuronal death in the gerbil hippocampus following transient ischemia. Brain Res. 540:116–122.
Enz, A., Amstutz, R., Hofmann, A., Gmelin, G., and Kelly, P. H. 1989. Pharmacological properties of the preferentially centrally acting acetylcholinesterase inhibitor SDZ ENA 713. 271–277, in Kewitz, Thomsen and Bickel, Pharmacological Interventions on Central Cholinergic Mechanisms in Senile Dementia (Alzheimer's Disease), W. Zuchschwerdt Verlag, Munchen.
Tanaka, K., Ogawa, N., Asanuma, M., Hirata, H., Kondo, Y., Nakayama, N., and Mori, A. in press. Effects of the acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain. Arch. Int. Pharmacodyn.
Gibson, G. E., and Duffy, T. E. 1981. impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrous oxide. J. Neurochem. 36:28–33.
Ogawa, N., Haba, K., Yoshikawa, H., Ono, T., and Mizukawa, K. 1988. Comparison of the effects of bifemelane hydrochloride on ischemia-induced depletion of brain acetylcholine levels in gerbils. Res. Commun. Chem. Pathol. Pharmacol. 61:285–288.
Glowinski, J., and Iversen, L. 1966. Regional studies of catecholamines in the rat brain I. J. Neurochem. 13:655–669.
Fujimori, K., and Yamamoto, K. 1987. Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J. Chromatogr. 414:167–173.
Haba, K., Ogawa, N., Kawata, M., and Mori, A. 1988. A method for parallel determination of choline acetyltransferase and muscarinic cholinergic receptors: application in aged-rat brain. Neurochem. Res. 13:951–955.
Rappaport, F., Fischi, J., and Pinto, N. 1959. An improved method for the estimation of cholinesterase activity in serum. Clin Chim Acta 4:227–230.
Ogawa, N., Mizuno, S., Nukina, I., Tsukamoto, S., and Mori, A. 1983. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS. Brain Res. 263:348–350.
Kogure, K., Scheinberg, P., Matsumoto, A., Busto, R., and Reinmuth, O. M. 1975. Catecholamines in experimental brain ischemia. Arch. Neurol. 32:21–24.
Ogawa, N., Haba, K., Asanuma, M., Mizukawa, K., and Mori, A. 1991. Super-delayed changes of muscarinic acetylcholine receptor in the gerbil hippocampus following transient ischemia. Adv. Exp. Med. Biol. 287:343–347.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, K., Ogawa, N., Mizukawa, K. et al. Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia. Neurochem Res 19, 117–122 (1994). https://doi.org/10.1007/BF00966804
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00966804